Skip to main content
Emerging Pharmaceutical Sciences and Innovation

Emerging Pharmaceutical Sciences and Innovation (EPSI)

Open Access (OA) Journal

Emerging Pharmaceutical Sciences and Innovation is an international peer-reviewed academic platform dedicated to advancing cutting-edge research in pharmaceutical sciences, drug discovery, clinical therapeutics, and translational medicine. The journal serves as a multidisciplinary forum for scientists, researchers, healthcare professionals, and industry experts to share innovative findings that contribute to the development of safe, effective, and accessible medicines, published biannually online by Tecno Scientifica. Open Access — free for readers and authors, with no article processing charges.  Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 3 weeks after submission. . About EPSI journal | All volumes & issues

Aims

The journal emphasizes emerging technologies, novel therapeutic strategies, and innovative pharmaceutical practices that address current and future global health challenges, particularly in developing and resource-limited settings. It promotes high-quality research that bridges the gap between laboratory discoveries and real-world clinical and industrial applications.

By fostering scientific exchange and interdisciplinary collaboration, the journal aims to support the advancement of pharmaceutical knowledge, improve healthcare outcomes, and accelerate innovation in drug development and delivery systems.

Focus & Scopes

The journal welcomes original research articles, reviews, case studies, and short communications in, but not limited to, the following areas:

  • Drug discovery and design, including computational and experimental approaches
  • Natural products and bioactive compound isolation for therapeutic development
  • Pharmaceutical nanotechnology and advanced drug delivery systems
  • Pharmacokinetics, pharmacodynamics, and ADMET studies
  • Clinical pharmacy and translational pharmaceutical research
  • Pharmaceutics and formulation development of novel dosage forms
  • Pharmaceutical biotechnology and biopharmaceutical production
  • Precision medicine, pharmacogenomics, and personalized therapy
  • Artificial intelligence and machine learning in drug development and pharmacy practice
  • Regulatory science, quality assurance, and pharmaceutical innovation policy

The journal encourages interdisciplinary submissions that integrate pharmaceutical sciences with biomedical engineering, data science, environmental health, and clinical research to address pressing global health challenges and promote innovation in healthcare systems worldwide.